Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

Clinical trial NCT00464880 · COMPLETED

Trial details

NCT number: NCT00464880
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Type 2

Start date: 2005-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.